3 Shares To Get Rich: GlaxoSmithKline plc, National Grid plc And Lloyds Banking Group PLC

Here are 3 companies that could improve your bottom line: GlaxoSmithKline plc (LON: GSK), National Grid plc (LON: NG) And Lloyds Banking Group PLC (LON: LLOY)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cash

Even though the FTSE 100 has pulled back in recent weeks and the future looks decidedly uncertain, in the long run investing in shares should pay off. Indeed, for investors willing to take risk, now could prove to be a great time to buy shares in top quality companies at slightly depressed prices.

Of course, no one company is likely to make you an millionaire overnight, but the following three stocks all trade at attractive valuations, have strong prospects and impressive yields. As such, they could help to improve your financial outlook.

GlaxoSmithKline

It’s been a tough time to be a GlaxoSmithKline (LSE: GSK) shareholder recently, with the company’s share price being hit due to allegations of corruption in China. However, looking ahead, GlaxoSmithKline has huge potential.

For starters, its pipeline is very strong and very well-diversified, with the potential to boost the company’s bottom line well into the future. In addition, shares in the company now trade on a price to earnings (P/E) ratio of just 12.3, which is significantly below the FTSE 100’s P/E of 13.3, while they currently yield a whopping 5.9%. As such, they could make for a profitable investment.

National Grid

One stock that is happy to be out of the headlines is National Grid (LSE: NG). While sector peers such as Centrica and SSE are continually bashed by the media, National Grid seems to make quiet progress while offering investors stunning income potential.

Indeed, the company currently yields an impressive 5.1% — but what matters more to investors is the company’s aim to increase dividend in-line with inflation over the medium term. This goal could mean sentiment improves for National Grid going forward, as a loose monetary policy is likely to mean higher rates of inflation in future years.

Lloyds

Lloyds (LSE: LLOY) had a fantastic year in 2013, with shares in the part government-owned bank rising by an incredible 61%. Of course, 2014 was bound to be a disappointment after such strong gains, but even so, many investors have been surprised at just how badly Lloyds has performed this year, with shares in the bank being down 7% year-to-date. However, this presents an opportunity to buy a stake in what looks set to be a very attractive income play.

Lloyds is forecast to pay a dividend of 3.2p per share next year, which at current prices equates to a yield of 4.4%. Furthermore, with profits and dividends set to increase over the next few years, Lloyds could see its share price bid up as investors seek out both strong growth potential and a generous yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline, Lloyds Banking Group, SSE, Centrica and National Grid. The Motley Fool has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Want a £1,320 passive income in 2025? These 2 UK shares could deliver it!

These dividend stocks have long histories of paying large and growing dividends. They're tipped to deliver more huge rewards in…

Read more »

Investing Articles

With P/E ratios below 8, I think these FTSE 250 shares are bargains!

The forward P/E ratios on these FTSE 250 shares are far below the index average of 14.1 times. I think…

Read more »

Investing Articles

Are stocks and shares the only way to become an ISA millionaire?

With Cash ISAs offering 5%, do stocks and shares make sense at the moment? Over the longer term, Stephen Wright…

Read more »

Dividend Shares

4,775 shares in this dividend stock could yield me £1.6k a year in passive income

Jon Smith explains how he can build passive income from dividend payers via regular investing that can compound quickly.

Read more »

Investing Articles

Is the Rolls-Royce share price heading to 655p? This analyst thinks so

While the Rolls-Royce share price continues to thrash the FTSE 100, this writer has a couple of things on his…

Read more »

Investing Articles

What’s going on with the National Grid share price now?

Volatility continues for the National Grid share price. Is this a warning sign for investors to heed or a buying…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
US Stock

This is a huge week for Nvidia stock

It’s a make-or-break week for Nvidia stock as the company is posting its Q3 earnings on Wednesday. Here’s what investors…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

After crashing 50% this FTSE value stock looks filthy cheap with a P/E of just 9.1%

Harvey Jones has some unfinished business with this FTSE 100 value stock, which he reckons has been harshly treated by…

Read more »